en · de · es · fr · pt
semax-notes.peptides6088.com › Info › Background And Development History — Complete Guide

Background And Development History — Complete Guide

By Editorial Desk · published 2026-05-29 · last reviewed 2026-06-25 · Info

intranasal delivery comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-06-25. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Development History

Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.

Mechanisms and Research Directions

Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.

Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.

Semax at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptideAnalogue of the ACTH(4-10) fragment
Amino acid sequenceMet-Glu-His-Phe-Pro-Gly-ProSingle-letter form MEHFPGP
Molecular formulaC37H51N9O10SFree peptide, nominal mass near 814 Da
First registration1994, RussiaNasal formulation for neurological indications
Typical purity grade95% or higher by HPLCResearch material; higher grades used as reference standards

Semax Background and Molecular Structure

The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.

Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.

Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.

Related pages on this site

Handling, Storage, and Analytical Methods

Quality documentation for research-grade peptide usually includes a certificate of analysis stating purity, identity, and residual counterion content. Batch-to-batch variation in purity and salt form is a recognized issue, and comparisons across suppliers require attention to the exact counterion, for example acetate versus trifluoroacetate. Sequence verification by tandem mass spectrometry provides stronger evidence than a single mass measurement. For any study reporting biological results, the analytical method and the measured purity should be stated explicitly. Independent verification of supplier claims is considered good practice.

Semax is supplied as a lyophilized powder that appears white to off-white. It dissolves readily in water, phosphate-buffered saline, and other aqueous media, which simplifies preparation of working solutions for laboratory use. The nasal products registered in Russia are dilute aqueous solutions, typically around 0.1 percent peptide by weight. Organic solvents are rarely necessary and can complicate handling. Because the peptide is hygroscopic, weighing should be performed quickly and with minimal exposure to ambient humidity.

Further detail

==== Art and design of Dishonored ==== Antonov's team was also inspired by older stealth action games developed by Ion Storm and Looking Glass Studios; Robert Purchese wrote for Eurogamer that this likely included Thief: The Dark Project (1998) and Deus Ex (2000). The game's "stylised" character designs were inspired by the "flamboyant" illustrations made for older adventure novels, especially ones about pirates such as Captain Blood (1922). In some cases, rather than using industry artists, Dishonored's developers hired industrial engineers, industrial designers, and other professionals in non-industry fields—including illustrators from Russia—to design the game's assets, as they felt this would make Dunwall's exotic, industrial scenery feel more authentic. For example, Antonov and Sébastien Mitton tracked down a specific textile carpet designer in Russia to have them make key art for the game. Most of the character design was done by professional anatomists. Antonov's main goal in designing Dunwall was "to reduce the scope and increase the density of experience" in exploring game worlds. Inside the city's "claustrophobic" areas, players can navigate small spaces like the underside of a table, and are able to reach and enter any location they can see while playing. Controlling Corvo Attano, an assassin given magical abilities, the player is aided in exploring small spaces by possessing any rats they see in the world, and can use the rat's burrows as shortcuts between locations.

=== Environmental chemistry === An important goal of environmental chemistry is tracing the source and degradation of pollutants. Various methods have been used for fingerprinting pools of environmental pollutants such as the bulk chemical composition of a spill, isotope ratios of the bulk chemical mixture, or isotope ratios of individual constituent compounds. Stable isotopes of carbon and hydrogen can be used as complementary fingerprinting techniques for natural gas. The DHR of hydrocarbons from the Deepwater Horizon oil spill was used to verify that they were likely from the Macondo well. HICs have also been used as a measure of the relative amount of biodegradation that has occurred in oil reservoirs in China, and studies on pure cultures of n-alkane degrading organisms have shown a chain-length dependence on the amount of hydrogen isotope fractionation during degradation. Additional studies have also shown hydrogen isotope effects in the degradation of methyl tert-butyl ether and toluene that have been suggested to be useful in the evaluation of the level of degradation of these polluting compounds in the environment. In both cases the residual unreacted compounds became 2H-enriched to a few tens of ‰, with variations exhibited between different organisms and degree of reaction completeness. These observations of heavy residual compounds have been applied to field observations of biodegradation reactions such as removal of benzene and ethylbenzene, which imparted a D/H fractionation of 27 and 50 ‰, respectively.

=== NutraSweet Company === In 1985, Monsanto bought G.D. Searle, and the aspartame business became a separate Monsanto subsidiary, NutraSweet. In March 2000, Monsanto sold it to J.W. Childs Associates Equity Partners II L.P. European use patents on aspartame expired beginning in 1987, with the US patent following suit in 1992.

Woods assures Biko that he will meet with a Government official to discuss the matter. Woods then meets with Jimmy Kruger (John Thaw), the South African Minister of Justice, in his house in Pretoria in an attempt to prevent further abuses. Minister Kruger first expresses discontent over their actions; however, Woods is later harassed at his home by security forces, who insinuate that their orders came directly from Kruger. Later, Biko travels to Cape Town to speak at a student-run meeting. En route, security forces stop his car and arrest him asking him to say his name, and he says, "Bantu Stephen Biko". He is held in harsh conditions and beaten, causing a severe brain injury. A doctor recommends consulting a nearby specialist in order to best treat his injuries, but the police refuse out of fear that he might escape. The security forces instead decide to take him to a police hospital in Pretoria, around 700 miles (1,100 km) away from Cape Town. He is thrown into the back of a prison van and driven on a bumpy road, aggravating his brain injury and resulting in his death. Woods then works to expose the police's complicity in Biko's death. He attempts to expose photographs of Biko's body that contradict police reports that he died of a hunger strike, but he is prevented just before boarding a plane to leave and informed that he is now 'banned', therefore not able to leave the country.

RCH=CH2 + H2 + CO → RCH2−CH2CHO Rh-based hydroformylation underpins the industrial production of products as diverse as detergents, fragrances, and some drugs. Rhodium based catalysts have 1000 to 10000 times higher activity for hydroformylation than cheaper cobalt carbonyl-based catalysts, allowing reactions at lower temperatures and pressures. Rhodium is also known to catalyze many reactions involving hydrogen gas and hydrosilanes. These include hydrogenations and hydrosilylations of alkenes. Rhodium metal, but not rhodium complexes, catalyzes the hydrogenation of benzene to cyclohexane.

Sources: en.wikipedia.org

Background from the literature

Pharmacokinetic data of oral trifluridine have only been evaluated in combination with tipiracil, which significantly affects biotransformation of the former. At least 57% of trifluridine are absorbed from the gut, and highest blood plasma concentrations are reached after two hours in cancer patients. The substance has no tendency to accumulate in the body. Plasma protein binding is over 96%. Trifluridine is metabolised by the enzyme thymidine phosphorylase to 5-trifluoromethyl-2,4(1H,3H)-pyrimidinedione (FTY), and also by glucuronidation. Elimination half-life is 1.4 hours on the first day and increases to 2.1 hours on the twelfth day. It is mainly excreted via the kidneys. Tipiracil causes Cmax (highest blood plasma concentrations) of trifluridine to increase 22-fold, and its area under the curve 37-fold, by inhibiting thymidine phosphorylase.

Plantar fascial fibromatosis, also known as Ledderhose's disease, Morbus Ledderhose, and plantar fibromatosis, is a relatively uncommon non-malignant thickening of the feet's deep connective tissue, or fascia. In the beginning, where nodules start growing in the fascia of the foot, the disease is minor. Over time, walking becomes painful. The disease is named after Georg Ledderhose, a German surgeon who described the condition for the first time in 1894. A similar disease is Dupuytren's disease, which affects the hand and causes bent hand or fingers. As in most forms of fibromatosis, it is usually benign and its onset varies with each patient. The nodules are typically slow-growing and most often found in the central and medial portions of the plantar fascia. Occasionally, the nodules may lie dormant for months to years only to begin rapid and unexpected growth. Options for intervention include radiation therapy, cryosurgery, treatment with collagenase clostridium histolyticum, or surgical removal only if discomfort hinders walking. In 2020, the World Health Organization reclassified plantar fibromatosis as a specific type of tumor in the category of intermediate (locally aggressive) fibroblastic and myofibroblastic tumors.

== Difficulty of separation == Unlike plutonium, minor actinides, fission products, or activation products, chemical processes cannot separate 236U from 238U, 235U, 232U or other uranium isotopes. It is even difficult to remove with isotopic separation, as low enrichment will concentrate not only the desirable 235U and 233U but the undesirable 236U, 234U and 232U. On the other hand, 236U in the environment cannot separate from 238U and concentrate separately, which limits its radiation hazard in any one place.

The stage was also an important part of Thomas's life from 1929 to 1934, as an actor, writer, producer and set painter. He took part in productions at Swansea Grammar School, and with the YMCA Junior Players and the Little Theatre, which was based in the Mumbles. It was also a touring company that took part in drama competitions and festivals around South Wales. Between October 1933 and March 1934, for example, Thomas and his fellow actors took part in five productions at the Mumbles theatre, as well as nine touring performances. Thomas continued with acting and production throughout his life, including his time in Laugharne, South Leigh and London (in the theatre and on radio), as well as taking part in nine stage readings of Under Milk Wood. The Shakespearian actor, John Laurie, who had worked with Thomas on both the stage and radio thought that Thomas would "have loved to have been an actor" and, had he chosen to do so, would have been "Our first real poet-dramatist since Shakespeare." Painting the sets at the Little Theatre was just one aspect of the young Thomas's interest in art. His own drawings and paintings hung in his bedroom in Cwmdonkin Drive, and his early letters reveal a broader interest in art and art theory. Thomas saw writing a poem as an act of construction "as a sculptor works at stone," later advising a student "to treat words as a craftsman does his wood or stone...hew, carve, mould, coil, polish and plane them..." Throughout his life, his friends included artists, both in Swansea and in London, as well as in America.

Sources: en.wikipedia.org

Frequently asked questions

In which form is semax typically supplied?

Registered medical products are most often 0.1% nasal drops. Research suppliers ship lyophilized powder, usually in milligram quantities, which is dissolved before use. The active peptide is the same in both cases; presentation and excipients differ.

Does semax occur naturally?

No. The peptide is synthetic, although it is modelled on a fragment of a naturally occurring hormone. ACTH(4-10) is generated when ACTH is cleaved, but the Pro-Gly-Pro extension is not a known endogenous sequence. It is therefore a designed analogue rather than a natural metabolite.

Why is it grouped with nootropics?

The label reflects reported effects on attention, memory and recovery after neurological injury in regional clinical reports. Those reports are mostly small and have not been widely replicated outside the region. The classification is descriptive and does not imply a single defined mechanism.

What is the leading proposed mechanism?

The main proposal is modulation of neurotrophic factors such as brain-derived neurotrophic factor, supported largely by animal experiments. Receptor-level targets have not been firmly established. Most reviews describe the mechanism as only partially characterized.

Network